Brief: Ryvu Therapeutics Says 'PERO' Project Recommended For Funding By National Centre For Research And Development
22/01/2026 14:55
Jan 22 (Reuters) - Ryvu Therapeutics SA RVU.WA: "PERO" PROJECT RECOMMENDED FOR FUNDING BY NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT (NCBR) PROJECT AIMS TO CREATE PLATFORM FOR VALIDATION OF THERAPEUTIC TARGETS IN ONCOLOGY TOTAL PROJECT VALUE IS 32.35 MILLION ZLOTYS, RECOMMENDED FUNDING AMOUNT IS 19.96 MILLION ZLOTYS Source text: ID:nEM3DW77Ha Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys